Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chavanet

Showing results (71-80 of 141) with videos related to

Pageof 15
Sort By:
The Journal of Antimicrobial Chemotherapy|September 1, 1984
Treatment of severe staphylococcal infections with cefotaxime and fosfomycin in combinationH Portier, J C Tremeaux, P Chavanet, et al.
Antimicrobial Agents and Chemotherapy|November 20, 2019
Activity of Different Antistaphylococcal Therapies, Alone or Combined, in a Rat Model of Methicillin-Resistant Staphylococcus epidermidis Osteitis without ImplantS Albac, D Labrousse, D Hayez, et al.
Medecine Et Maladies Infectieuses|April 10, 2019
Influenza infection and bacteremic pneumococcal pneumoniaM Blot, R Bruyère, P Chavanet, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1996
In-vivo activity and pharmacodynamics of cefotaxime in combination with vancomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniaeP Chavanet, D Champliaud, A Pechinot, et al.
Presse Medicale (Paris, France : 1983)|March 27, 1999
[Discontinuing protease inhibitor treatment of HIV-1 patients for intolerance. Longitudinal study of 309 patients]L Piroth, M Grappin, A Waldner, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1996
In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniaeP Chavanet, N Peyrard, A Pechinot, et al.
Medecine Et Maladies Infectieuses|December 26, 2008
[Incidence, prevalence and risk factors for a first infectious complication on a totally implantable venous-access port]M Crisinel, S Mahy, P Ortega-Debalon, et al.
HIV Clinical Trials|October 9, 2001
Evaluation of the Patient Medication Adherence Questionnaire as a tool for self-reported adherence assessment in HIV-infected patients on antiretroviral regimensM Duong, L Piroth, M Grappin, et al.
Presse Medicale (Paris, France : 1983)|April 22, 1989
[A simplified method of vaccination against rabies after exposure]P Chavanet, P Sureau, A Waldner-Combernoux, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 29, 2006
In-vivo impact of the MexXY efflux system on aminoglycoside efficacy in an experimental model of Pseudomonas aeruginosa pneumonia treated with tobramycinB Martha, D Croisier, D Durand, et al.
Pageof 15

Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
The Journal of Antimicrobial Chemotherapy|September 1, 1984
Treatment of severe staphylococcal infections with cefotaxime and fosfomycin in combinationH Portier, J C Tremeaux, P Chavanet, et al.
Antimicrobial Agents and Chemotherapy|November 20, 2019
Activity of Different Antistaphylococcal Therapies, Alone or Combined, in a Rat Model of Methicillin-Resistant Staphylococcus epidermidis Osteitis without ImplantS Albac, D Labrousse, D Hayez, et al.
Medecine Et Maladies Infectieuses|April 10, 2019
Influenza infection and bacteremic pneumococcal pneumoniaM Blot, R Bruyère, P Chavanet, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1996
In-vivo activity and pharmacodynamics of cefotaxime in combination with vancomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniaeP Chavanet, D Champliaud, A Pechinot, et al.
Presse Medicale (Paris, France : 1983)|March 27, 1999
[Discontinuing protease inhibitor treatment of HIV-1 patients for intolerance. Longitudinal study of 309 patients]L Piroth, M Grappin, A Waldner, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1996
In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniaeP Chavanet, N Peyrard, A Pechinot, et al.
Medecine Et Maladies Infectieuses|December 26, 2008
[Incidence, prevalence and risk factors for a first infectious complication on a totally implantable venous-access port]M Crisinel, S Mahy, P Ortega-Debalon, et al.
HIV Clinical Trials|October 9, 2001
Evaluation of the Patient Medication Adherence Questionnaire as a tool for self-reported adherence assessment in HIV-infected patients on antiretroviral regimensM Duong, L Piroth, M Grappin, et al.
Presse Medicale (Paris, France : 1983)|April 22, 1989
[A simplified method of vaccination against rabies after exposure]P Chavanet, P Sureau, A Waldner-Combernoux, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 29, 2006
In-vivo impact of the MexXY efflux system on aminoglycoside efficacy in an experimental model of Pseudomonas aeruginosa pneumonia treated with tobramycinB Martha, D Croisier, D Durand, et al.
Pageof 15